-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Upgrades Exagen to Overweight, Maintains Price Target to $12

Benzinga·07/30/2025 11:02:43
Listen to the news
Keybanc analyst Paul Knight upgrades Exagen (NASDAQ:XGN) from Sector Weight to Overweight and maintains the price target from $12 to $12.